Global Type 2 Diabetes Market Growth 2024-2030

Product Code: 789363

Industry: Pharma & Healthcare

Published: Jan 02,2024

Pages: 99

Delivery Time: 2-3 business days

Global Type 2 Diabetes Market Growth 2024-2030

Product Code: 789363

Industry: Pharma & Healthcare

Published: Jan 02,2024

Pages: 99

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

According to our LPI (LP Information) latest study, the global Type 2 Diabetes market size was valued at US$ 63700 million in 2023. With growing demand in downstream market, the Type 2 Diabetes is forecast to a readjusted size of US$ 117020 million by 2030 with a CAGR of 9.1% during review period. 
The research report highlights the growth potential of the global Type 2 Diabetes market. Type 2 Diabetes are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Type 2 Diabetes. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Type 2 Diabetes market.

Type 2 diabetes is a progressive condition in which the body becomes resistant to the normal effects of insulin and/or gradually loses the capacity to produce enough insulin in the pancreas. We do not know what causes type 2 diabetes. Type 2 diabetes is associated with modifiable lifestyle risk factors. Type 2 diabetes also has strong genetic and family related risk factors.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Key Features:
The report on Type 2 Diabetes market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Type 2 Diabetes market. It may include historical data, market segmentation by Type (e.g., Insulins, DPP-4 Inhibitors), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Type 2 Diabetes market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Type 2 Diabetes market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Type 2 Diabetes industry. This include advancements in Type 2 Diabetes technology, Type 2 Diabetes new entrants, Type 2 Diabetes new investment, and other innovations that are shaping the future of Type 2 Diabetes.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Type 2 Diabetes market. It includes factors influencing customer ' purchasing decisions, preferences for Type 2 Diabetes product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Type 2 Diabetes market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Type 2 Diabetes market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Type 2 Diabetes market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Type 2 Diabetes industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Type 2 Diabetes market.

Market Segmentation:
Type 2 Diabetes market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Segmentation by type
Insulins
DPP-4 Inhibitors
GLP-1 Receptor Agonists
SGLT-2 Inhibitors

Segmentation by application
Drugstore
Hospital
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Novo Nordisk
Sanofi
Merck
Eli Lily
AstraZeneca
Astellas Pharma
Daiichi Sankyo
Biocon
Boehringer Ingelheim

Key Questions Addressed in this Report
What is the 10-year outlook for the global Type 2 Diabetes market?
What factors are driving Type 2 Diabetes market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Type 2 Diabetes market opportunities vary by end market size?
How does Type 2 Diabetes break out type, application?

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Type 2 Diabetes Annual Sales 2019-2030
        2.1.2 World Current & Future Analysis for Type 2 Diabetes by Geographic Region, 2019, 2023 & 2030
        2.1.3 World Current & Future Analysis for Type 2 Diabetes by Country/Region, 2019, 2023 & 2030
    2.2 Type 2 Diabetes Segment by Type
        2.2.1 Insulins
        2.2.2 DPP-4 Inhibitors
        2.2.3 GLP-1 Receptor Agonists
        2.2.4 SGLT-2 Inhibitors
    2.3 Type 2 Diabetes Sales by Type
        2.3.1 Global Type 2 Diabetes Sales Market Share by Type (2019-2024)
        2.3.2 Global Type 2 Diabetes Revenue and Market Share by Type (2019-2024)
        2.3.3 Global Type 2 Diabetes Sale Price by Type (2019-2024)
    2.4 Type 2 Diabetes Segment by Application
        2.4.1 Drugstore
        2.4.2 Hospital
        2.4.3 Others
    2.5 Type 2 Diabetes Sales by Application
        2.5.1 Global Type 2 Diabetes Sale Market Share by Application (2019-2024)
        2.5.2 Global Type 2 Diabetes Revenue and Market Share by Application (2019-2024)
        2.5.3 Global Type 2 Diabetes Sale Price by Application (2019-2024)

3 Global Type 2 Diabetes by Company
    3.1 Global Type 2 Diabetes Breakdown Data by Company
        3.1.1 Global Type 2 Diabetes Annual Sales by Company (2019-2024)
        3.1.2 Global Type 2 Diabetes Sales Market Share by Company (2019-2024)
    3.2 Global Type 2 Diabetes Annual Revenue by Company (2019-2024)
        3.2.1 Global Type 2 Diabetes Revenue by Company (2019-2024)
        3.2.2 Global Type 2 Diabetes Revenue Market Share by Company (2019-2024)
    3.3 Global Type 2 Diabetes Sale Price by Company
    3.4 Key Manufacturers Type 2 Diabetes Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Type 2 Diabetes Product Location Distribution
        3.4.2 Players Type 2 Diabetes Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Type 2 Diabetes by Geographic Region
    4.1 World Historic Type 2 Diabetes Market Size by Geographic Region (2019-2024)
        4.1.1 Global Type 2 Diabetes Annual Sales by Geographic Region (2019-2024)
        4.1.2 Global Type 2 Diabetes Annual Revenue by Geographic Region (2019-2024)
    4.2 World Historic Type 2 Diabetes Market Size by Country/Region (2019-2024)
        4.2.1 Global Type 2 Diabetes Annual Sales by Country/Region (2019-2024)
        4.2.2 Global Type 2 Diabetes Annual Revenue by Country/Region (2019-2024)
    4.3 Americas Type 2 Diabetes Sales Growth
    4.4 APAC Type 2 Diabetes Sales Growth
    4.5 Europe Type 2 Diabetes Sales Growth
    4.6 Middle East & Africa Type 2 Diabetes Sales Growth

5 Americas
    5.1 Americas Type 2 Diabetes Sales by Country
        5.1.1 Americas Type 2 Diabetes Sales by Country (2019-2024)
        5.1.2 Americas Type 2 Diabetes Revenue by Country (2019-2024)
    5.2 Americas Type 2 Diabetes Sales by Type
    5.3 Americas Type 2 Diabetes Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Type 2 Diabetes Sales by Region
        6.1.1 APAC Type 2 Diabetes Sales by Region (2019-2024)
        6.1.2 APAC Type 2 Diabetes Revenue by Region (2019-2024)
    6.2 APAC Type 2 Diabetes Sales by Type
    6.3 APAC Type 2 Diabetes Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan

7 Europe
    7.1 Europe Type 2 Diabetes by Country
        7.1.1 Europe Type 2 Diabetes Sales by Country (2019-2024)
        7.1.2 Europe Type 2 Diabetes Revenue by Country (2019-2024)
    7.2 Europe Type 2 Diabetes Sales by Type
    7.3 Europe Type 2 Diabetes Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Type 2 Diabetes by Country
        8.1.1 Middle East & Africa Type 2 Diabetes Sales by Country (2019-2024)
        8.1.2 Middle East & Africa Type 2 Diabetes Revenue by Country (2019-2024)
    8.2 Middle East & Africa Type 2 Diabetes Sales by Type
    8.3 Middle East & Africa Type 2 Diabetes Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Type 2 Diabetes
    10.3 Manufacturing Process Analysis of Type 2 Diabetes
    10.4 Industry Chain Structure of Type 2 Diabetes

11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Type 2 Diabetes Distributors
    11.3 Type 2 Diabetes Customer

12 World Forecast Review for Type 2 Diabetes by Geographic Region
    12.1 Global Type 2 Diabetes Market Size Forecast by Region
        12.1.1 Global Type 2 Diabetes Forecast by Region (2025-2030)
        12.1.2 Global Type 2 Diabetes Annual Revenue Forecast by Region (2025-2030)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Type 2 Diabetes Forecast by Type
    12.7 Global Type 2 Diabetes Forecast by Application

13 Key Players Analysis
    13.1 Novo Nordisk
        13.1.1 Novo Nordisk Company Information
        13.1.2 Novo Nordisk Type 2 Diabetes Product Portfolios and Specifications
        13.1.3 Novo Nordisk Type 2 Diabetes Sales, Revenue, Price and Gross Margin (2019-2024)
        13.1.4 Novo Nordisk Main Business Overview
        13.1.5 Novo Nordisk Latest Developments
    13.2 Sanofi
        13.2.1 Sanofi Company Information
        13.2.2 Sanofi Type 2 Diabetes Product Portfolios and Specifications
        13.2.3 Sanofi Type 2 Diabetes Sales, Revenue, Price and Gross Margin (2019-2024)
        13.2.4 Sanofi Main Business Overview
        13.2.5 Sanofi Latest Developments
    13.3 Merck
        13.3.1 Merck Company Information
        13.3.2 Merck Type 2 Diabetes Product Portfolios and Specifications
        13.3.3 Merck Type 2 Diabetes Sales, Revenue, Price and Gross Margin (2019-2024)
        13.3.4 Merck Main Business Overview
        13.3.5 Merck Latest Developments
    13.4 Eli Lily
        13.4.1 Eli Lily Company Information
        13.4.2 Eli Lily Type 2 Diabetes Product Portfolios and Specifications
        13.4.3 Eli Lily Type 2 Diabetes Sales, Revenue, Price and Gross Margin (2019-2024)
        13.4.4 Eli Lily Main Business Overview
        13.4.5 Eli Lily Latest Developments
    13.5 AstraZeneca
        13.5.1 AstraZeneca Company Information
        13.5.2 AstraZeneca Type 2 Diabetes Product Portfolios and Specifications
        13.5.3 AstraZeneca Type 2 Diabetes Sales, Revenue, Price and Gross Margin (2019-2024)
        13.5.4 AstraZeneca Main Business Overview
        13.5.5 AstraZeneca Latest Developments
    13.6 Astellas Pharma
        13.6.1 Astellas Pharma Company Information
        13.6.2 Astellas Pharma Type 2 Diabetes Product Portfolios and Specifications
        13.6.3 Astellas Pharma Type 2 Diabetes Sales, Revenue, Price and Gross Margin (2019-2024)
        13.6.4 Astellas Pharma Main Business Overview
        13.6.5 Astellas Pharma Latest Developments
    13.7 Daiichi Sankyo
        13.7.1 Daiichi Sankyo Company Information
        13.7.2 Daiichi Sankyo Type 2 Diabetes Product Portfolios and Specifications
        13.7.3 Daiichi Sankyo Type 2 Diabetes Sales, Revenue, Price and Gross Margin (2019-2024)
        13.7.4 Daiichi Sankyo Main Business Overview
        13.7.5 Daiichi Sankyo Latest Developments
    13.8 Biocon
        13.8.1 Biocon Company Information
        13.8.2 Biocon Type 2 Diabetes Product Portfolios and Specifications
        13.8.3 Biocon Type 2 Diabetes Sales, Revenue, Price and Gross Margin (2019-2024)
        13.8.4 Biocon Main Business Overview
        13.8.5 Biocon Latest Developments
    13.9 Boehringer Ingelheim
        13.9.1 Boehringer Ingelheim Company Information
        13.9.2 Boehringer Ingelheim Type 2 Diabetes Product Portfolios and Specifications
        13.9.3 Boehringer Ingelheim Type 2 Diabetes Sales, Revenue, Price and Gross Margin (2019-2024)
        13.9.4 Boehringer Ingelheim Main Business Overview
        13.9.5 Boehringer Ingelheim Latest Developments

14 Research Findings and Conclusion

List Of Tables

List of Tables
    Table 1. Type 2 Diabetes Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
    Table 2. Type 2 Diabetes Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
    Table 3. Major Players of Insulins
    Table 4. Major Players of DPP-4 Inhibitors
    Table 5. Major Players of GLP-1 Receptor Agonists
    Table 6. Major Players of SGLT-2 Inhibitors
    Table 7. Global Type 2 Diabetes Sales by Type (2019-2024) & (K Units)
    Table 8. Global Type 2 Diabetes Sales Market Share by Type (2019-2024)
    Table 9. Global Type 2 Diabetes Revenue by Type (2019-2024) & ($ million)
    Table 10. Global Type 2 Diabetes Revenue Market Share by Type (2019-2024)
    Table 11. Global Type 2 Diabetes Sale Price by Type (2019-2024) & (USD/Unit)
    Table 12. Global Type 2 Diabetes Sales by Application (2019-2024) & (K Units)
    Table 13. Global Type 2 Diabetes Sales Market Share by Application (2019-2024)
    Table 14. Global Type 2 Diabetes Revenue by Application (2019-2024)
    Table 15. Global Type 2 Diabetes Revenue Market Share by Application (2019-2024)
    Table 16. Global Type 2 Diabetes Sale Price by Application (2019-2024) & (USD/Unit)
    Table 17. Global Type 2 Diabetes Sales by Company (2019-2024) & (K Units)
    Table 18. Global Type 2 Diabetes Sales Market Share by Company (2019-2024)
    Table 19. Global Type 2 Diabetes Revenue by Company (2019-2024) ($ Millions)
    Table 20. Global Type 2 Diabetes Revenue Market Share by Company (2019-2024)
    Table 21. Global Type 2 Diabetes Sale Price by Company (2019-2024) & (USD/Unit)
    Table 22. Key Manufacturers Type 2 Diabetes Producing Area Distribution and Sales Area
    Table 23. Players Type 2 Diabetes Products Offered
    Table 24. Type 2 Diabetes Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
    Table 25. New Products and Potential Entrants
    Table 26. Mergers & Acquisitions, Expansion
    Table 27. Global Type 2 Diabetes Sales by Geographic Region (2019-2024) & (K Units)
    Table 28. Global Type 2 Diabetes Sales Market Share Geographic Region (2019-2024)
    Table 29. Global Type 2 Diabetes Revenue by Geographic Region (2019-2024) & ($ millions)
    Table 30. Global Type 2 Diabetes Revenue Market Share by Geographic Region (2019-2024)
    Table 31. Global Type 2 Diabetes Sales by Country/Region (2019-2024) & (K Units)
    Table 32. Global Type 2 Diabetes Sales Market Share by Country/Region (2019-2024)
    Table 33. Global Type 2 Diabetes Revenue by Country/Region (2019-2024) & ($ millions)
    Table 34. Global Type 2 Diabetes Revenue Market Share by Country/Region (2019-2024)
    Table 35. Americas Type 2 Diabetes Sales by Country (2019-2024) & (K Units)
    Table 36. Americas Type 2 Diabetes Sales Market Share by Country (2019-2024)
    Table 37. Americas Type 2 Diabetes Revenue by Country (2019-2024) & ($ Millions)
    Table 38. Americas Type 2 Diabetes Revenue Market Share by Country (2019-2024)
    Table 39. Americas Type 2 Diabetes Sales by Type (2019-2024) & (K Units)
    Table 40. Americas Type 2 Diabetes Sales by Application (2019-2024) & (K Units)
    Table 41. APAC Type 2 Diabetes Sales by Region (2019-2024) & (K Units)
    Table 42. APAC Type 2 Diabetes Sales Market Share by Region (2019-2024)
    Table 43. APAC Type 2 Diabetes Revenue by Region (2019-2024) & ($ Millions)
    Table 44. APAC Type 2 Diabetes Revenue Market Share by Region (2019-2024)
    Table 45. APAC Type 2 Diabetes Sales by Type (2019-2024) & (K Units)
    Table 46. APAC Type 2 Diabetes Sales by Application (2019-2024) & (K Units)
    Table 47. Europe Type 2 Diabetes Sales by Country (2019-2024) & (K Units)
    Table 48. Europe Type 2 Diabetes Sales Market Share by Country (2019-2024)
    Table 49. Europe Type 2 Diabetes Revenue by Country (2019-2024) & ($ Millions)
    Table 50. Europe Type 2 Diabetes Revenue Market Share by Country (2019-2024)
    Table 51. Europe Type 2 Diabetes Sales by Type (2019-2024) & (K Units)
    Table 52. Europe Type 2 Diabetes Sales by Application (2019-2024) & (K Units)
    Table 53. Middle East & Africa Type 2 Diabetes Sales by Country (2019-2024) & (K Units)
    Table 54. Middle East & Africa Type 2 Diabetes Sales Market Share by Country (2019-2024)
    Table 55. Middle East & Africa Type 2 Diabetes Revenue by Country (2019-2024) & ($ Millions)
    Table 56. Middle East & Africa Type 2 Diabetes Revenue Market Share by Country (2019-2024)
    Table 57. Middle East & Africa Type 2 Diabetes Sales by Type (2019-2024) & (K Units)
    Table 58. Middle East & Africa Type 2 Diabetes Sales by Application (2019-2024) & (K Units)
    Table 59. Key Market Drivers & Growth Opportunities of Type 2 Diabetes
    Table 60. Key Market Challenges & Risks of Type 2 Diabetes
    Table 61. Key Industry Trends of Type 2 Diabetes
    Table 62. Type 2 Diabetes Raw Material
    Table 63. Key Suppliers of Raw Materials
    Table 64. Type 2 Diabetes Distributors List
    Table 65. Type 2 Diabetes Customer List
    Table 66. Global Type 2 Diabetes Sales Forecast by Region (2025-2030) & (K Units)
    Table 67. Global Type 2 Diabetes Revenue Forecast by Region (2025-2030) & ($ millions)
    Table 68. Americas Type 2 Diabetes Sales Forecast by Country (2025-2030) & (K Units)
    Table 69. Americas Type 2 Diabetes Revenue Forecast by Country (2025-2030) & ($ millions)
    Table 70. APAC Type 2 Diabetes Sales Forecast by Region (2025-2030) & (K Units)
    Table 71. APAC Type 2 Diabetes Revenue Forecast by Region (2025-2030) & ($ millions)
    Table 72. Europe Type 2 Diabetes Sales Forecast by Country (2025-2030) & (K Units)
    Table 73. Europe Type 2 Diabetes Revenue Forecast by Country (2025-2030) & ($ millions)
    Table 74. Middle East & Africa Type 2 Diabetes Sales Forecast by Country (2025-2030) & (K Units)
    Table 75. Middle East & Africa Type 2 Diabetes Revenue Forecast by Country (2025-2030) & ($ millions)
    Table 76. Global Type 2 Diabetes Sales Forecast by Type (2025-2030) & (K Units)
    Table 77. Global Type 2 Diabetes Revenue Forecast by Type (2025-2030) & ($ Millions)
    Table 78. Global Type 2 Diabetes Sales Forecast by Application (2025-2030) & (K Units)
    Table 79. Global Type 2 Diabetes Revenue Forecast by Application (2025-2030) & ($ Millions)
    Table 80. Novo Nordisk Basic Information, Type 2 Diabetes Manufacturing Base, Sales Area and Its Competitors
    Table 81. Novo Nordisk Type 2 Diabetes Product Portfolios and Specifications
    Table 82. Novo Nordisk Type 2 Diabetes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. Novo Nordisk Main Business
    Table 84. Novo Nordisk Latest Developments
    Table 85. Sanofi Basic Information, Type 2 Diabetes Manufacturing Base, Sales Area and Its Competitors
    Table 86. Sanofi Type 2 Diabetes Product Portfolios and Specifications
    Table 87. Sanofi Type 2 Diabetes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. Sanofi Main Business
    Table 89. Sanofi Latest Developments
    Table 90. Merck Basic Information, Type 2 Diabetes Manufacturing Base, Sales Area and Its Competitors
    Table 91. Merck Type 2 Diabetes Product Portfolios and Specifications
    Table 92. Merck Type 2 Diabetes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. Merck Main Business
    Table 94. Merck Latest Developments
    Table 95. Eli Lily Basic Information, Type 2 Diabetes Manufacturing Base, Sales Area and Its Competitors
    Table 96. Eli Lily Type 2 Diabetes Product Portfolios and Specifications
    Table 97. Eli Lily Type 2 Diabetes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. Eli Lily Main Business
    Table 99. Eli Lily Latest Developments
    Table 100. AstraZeneca Basic Information, Type 2 Diabetes Manufacturing Base, Sales Area and Its Competitors
    Table 101. AstraZeneca Type 2 Diabetes Product Portfolios and Specifications
    Table 102. AstraZeneca Type 2 Diabetes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 103. AstraZeneca Main Business
    Table 104. AstraZeneca Latest Developments
    Table 105. Astellas Pharma Basic Information, Type 2 Diabetes Manufacturing Base, Sales Area and Its Competitors
    Table 106. Astellas Pharma Type 2 Diabetes Product Portfolios and Specifications
    Table 107. Astellas Pharma Type 2 Diabetes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 108. Astellas Pharma Main Business
    Table 109. Astellas Pharma Latest Developments
    Table 110. Daiichi Sankyo Basic Information, Type 2 Diabetes Manufacturing Base, Sales Area and Its Competitors
    Table 111. Daiichi Sankyo Type 2 Diabetes Product Portfolios and Specifications
    Table 112. Daiichi Sankyo Type 2 Diabetes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 113. Daiichi Sankyo Main Business
    Table 114. Daiichi Sankyo Latest Developments
    Table 115. Biocon Basic Information, Type 2 Diabetes Manufacturing Base, Sales Area and Its Competitors
    Table 116. Biocon Type 2 Diabetes Product Portfolios and Specifications
    Table 117. Biocon Type 2 Diabetes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 118. Biocon Main Business
    Table 119. Biocon Latest Developments
    Table 120. Boehringer Ingelheim Basic Information, Type 2 Diabetes Manufacturing Base, Sales Area and Its Competitors
    Table 121. Boehringer Ingelheim Type 2 Diabetes Product Portfolios and Specifications
    Table 122. Boehringer Ingelheim Type 2 Diabetes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 123. Boehringer Ingelheim Main Business
    Table 124. Boehringer Ingelheim Latest Developments
List of Figures
    Figure 1. Picture of Type 2 Diabetes
    Figure 2. Type 2 Diabetes Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Type 2 Diabetes Sales Growth Rate 2019-2030 (K Units)
    Figure 7. Global Type 2 Diabetes Revenue Growth Rate 2019-2030 ($ Millions)
    Figure 8. Type 2 Diabetes Sales by Region (2019, 2023 & 2030) & ($ Millions)
    Figure 9. Product Picture of Insulins
    Figure 10. Product Picture of DPP-4 Inhibitors
    Figure 11. Product Picture of GLP-1 Receptor Agonists
    Figure 12. Product Picture of SGLT-2 Inhibitors
    Figure 13. Global Type 2 Diabetes Sales Market Share by Type in 2023
    Figure 14. Global Type 2 Diabetes Revenue Market Share by Type (2019-2024)
    Figure 15. Type 2 Diabetes Consumed in Drugstore
    Figure 16. Global Type 2 Diabetes Market: Drugstore (2019-2024) & (K Units)
    Figure 17. Type 2 Diabetes Consumed in Hospital
    Figure 18. Global Type 2 Diabetes Market: Hospital (2019-2024) & (K Units)
    Figure 19. Type 2 Diabetes Consumed in Others
    Figure 20. Global Type 2 Diabetes Market: Others (2019-2024) & (K Units)
    Figure 21. Global Type 2 Diabetes Sales Market Share by Application (2023)
    Figure 22. Global Type 2 Diabetes Revenue Market Share by Application in 2023
    Figure 23. Type 2 Diabetes Sales Market by Company in 2023 (K Units)
    Figure 24. Global Type 2 Diabetes Sales Market Share by Company in 2023
    Figure 25. Type 2 Diabetes Revenue Market by Company in 2023 ($ Million)
    Figure 26. Global Type 2 Diabetes Revenue Market Share by Company in 2023
    Figure 27. Global Type 2 Diabetes Sales Market Share by Geographic Region (2019-2024)
    Figure 28. Global Type 2 Diabetes Revenue Market Share by Geographic Region in 2023
    Figure 29. Americas Type 2 Diabetes Sales 2019-2024 (K Units)
    Figure 30. Americas Type 2 Diabetes Revenue 2019-2024 ($ Millions)
    Figure 31. APAC Type 2 Diabetes Sales 2019-2024 (K Units)
    Figure 32. APAC Type 2 Diabetes Revenue 2019-2024 ($ Millions)
    Figure 33. Europe Type 2 Diabetes Sales 2019-2024 (K Units)
    Figure 34. Europe Type 2 Diabetes Revenue 2019-2024 ($ Millions)
    Figure 35. Middle East & Africa Type 2 Diabetes Sales 2019-2024 (K Units)
    Figure 36. Middle East & Africa Type 2 Diabetes Revenue 2019-2024 ($ Millions)
    Figure 37. Americas Type 2 Diabetes Sales Market Share by Country in 2023
    Figure 38. Americas Type 2 Diabetes Revenue Market Share by Country in 2023
    Figure 39. Americas Type 2 Diabetes Sales Market Share by Type (2019-2024)
    Figure 40. Americas Type 2 Diabetes Sales Market Share by Application (2019-2024)
    Figure 41. United States Type 2 Diabetes Revenue Growth 2019-2024 ($ Millions)
    Figure 42. Canada Type 2 Diabetes Revenue Growth 2019-2024 ($ Millions)
    Figure 43. Mexico Type 2 Diabetes Revenue Growth 2019-2024 ($ Millions)
    Figure 44. Brazil Type 2 Diabetes Revenue Growth 2019-2024 ($ Millions)
    Figure 45. APAC Type 2 Diabetes Sales Market Share by Region in 2023
    Figure 46. APAC Type 2 Diabetes Revenue Market Share by Regions in 2023
    Figure 47. APAC Type 2 Diabetes Sales Market Share by Type (2019-2024)
    Figure 48. APAC Type 2 Diabetes Sales Market Share by Application (2019-2024)
    Figure 49. China Type 2 Diabetes Revenue Growth 2019-2024 ($ Millions)
    Figure 50. Japan Type 2 Diabetes Revenue Growth 2019-2024 ($ Millions)
    Figure 51. South Korea Type 2 Diabetes Revenue Growth 2019-2024 ($ Millions)
    Figure 52. Southeast Asia Type 2 Diabetes Revenue Growth 2019-2024 ($ Millions)
    Figure 53. India Type 2 Diabetes Revenue Growth 2019-2024 ($ Millions)
    Figure 54. Australia Type 2 Diabetes Revenue Growth 2019-2024 ($ Millions)
    Figure 55. China Taiwan Type 2 Diabetes Revenue Growth 2019-2024 ($ Millions)
    Figure 56. Europe Type 2 Diabetes Sales Market Share by Country in 2023
    Figure 57. Europe Type 2 Diabetes Revenue Market Share by Country in 2023
    Figure 58. Europe Type 2 Diabetes Sales Market Share by Type (2019-2024)
    Figure 59. Europe Type 2 Diabetes Sales Market Share by Application (2019-2024)
    Figure 60. Germany Type 2 Diabetes Revenue Growth 2019-2024 ($ Millions)
    Figure 61. France Type 2 Diabetes Revenue Growth 2019-2024 ($ Millions)
    Figure 62. UK Type 2 Diabetes Revenue Growth 2019-2024 ($ Millions)
    Figure 63. Italy Type 2 Diabetes Revenue Growth 2019-2024 ($ Millions)
    Figure 64. Russia Type 2 Diabetes Revenue Growth 2019-2024 ($ Millions)
    Figure 65. Middle East & Africa Type 2 Diabetes Sales Market Share by Country in 2023
    Figure 66. Middle East & Africa Type 2 Diabetes Revenue Market Share by Country in 2023
    Figure 67. Middle East & Africa Type 2 Diabetes Sales Market Share by Type (2019-2024)
    Figure 68. Middle East & Africa Type 2 Diabetes Sales Market Share by Application (2019-2024)
    Figure 69. Egypt Type 2 Diabetes Revenue Growth 2019-2024 ($ Millions)
    Figure 70. South Africa Type 2 Diabetes Revenue Growth 2019-2024 ($ Millions)
    Figure 71. Israel Type 2 Diabetes Revenue Growth 2019-2024 ($ Millions)
    Figure 72. Turkey Type 2 Diabetes Revenue Growth 2019-2024 ($ Millions)
    Figure 73. GCC Country Type 2 Diabetes Revenue Growth 2019-2024 ($ Millions)
    Figure 74. Manufacturing Cost Structure Analysis of Type 2 Diabetes in 2023
    Figure 75. Manufacturing Process Analysis of Type 2 Diabetes
    Figure 76. Industry Chain Structure of Type 2 Diabetes
    Figure 77. Channels of Distribution
    Figure 78. Global Type 2 Diabetes Sales Market Forecast by Region (2025-2030)
    Figure 79. Global Type 2 Diabetes Revenue Market Share Forecast by Region (2025-2030)
    Figure 80. Global Type 2 Diabetes Sales Market Share Forecast by Type (2025-2030)
    Figure 81. Global Type 2 Diabetes Revenue Market Share Forecast by Type (2025-2030)
    Figure 82. Global Type 2 Diabetes Sales Market Share Forecast by Application (2025-2030)
    Figure 83. Global Type 2 Diabetes Revenue Market Share Forecast by Application (2025-2030)

Companies Mentioned

Novo Nordisk

Sanofi

Merck

Eli Lily

AstraZeneca

Astellas Pharma

Daiichi Sankyo

Biocon

Boehringer Ingelheim

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff